GlycoMimetics
GlycoMimetics, Inc. engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, M...
GlycoMimetics Logo
About GlycoMimetics
GlycoMimetics, Inc. develops molecule drugs. The Company offers research, development, and commercialization of specialized small molecule drug compounds for the treatment of blood cancers and certain inflammatory conditions. GlycoMimetic operates in the United States.
Address
P.O. Box 65,
Monrovia, 21770
United States
Year founded
2003
Number of employees
4
